安全針:全球市場預測(2022年~2027年)
市場調查報告書
商品編碼
1071463

安全針:全球市場預測(2022年~2027年)

Global Safety Needles Market - Forecasts from 2022 to 2027

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球安全針的市場規模在2020年估算為3億8,180萬4,000萬美金,在預測期間內預計將以13.21%的年複合成長率擴大,2027年成為9億1,003萬5,000美元。市場成長的主要因素有增加疫苗接種以避免慢性疾病、老年人口增加以及對安全針頭的需求以改善身體健康。政府對醫療領域的大力投資也有望帶來穩定增長。

本報告提供安全針的世界市場調查,提供市場規模和預測,市場促進因素及課題,市場趨勢,各市場區隔的市場分析,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 假設

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 波特的五力分析
    • 供給企業談判力
    • 買方議價能力
    • 替代品的威脅
    • 新加入廠商者的威脅
    • 競爭企業間的敵對關係
  • 產業的價值鏈分析

第5章 全球安全針市場:各類型

  • 簡介
  • 活性安全針
  • 被動式安全針

第6章 全球安全針市場:各給藥途徑

  • 簡介
  • 皮下
  • 靜脈內
  • 其他

第7章 全球安全針市場:各終端用戶

  • 簡介
  • 醫院及診療所
  • 門診病人診療中心
  • 診斷中心
  • 其他

第8章 全球安全針市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 日本
    • 其他

第9章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業和市場收益性
  • 合併,收購,協定,及合作
  • 供應商競爭力矩陣

第10章 企業簡介

  • BD
  • Cardinal Health
  • B. Braun Melsungen Ag
  • Medline Industries, Inc.
  • Johnson & Johnson Services, Inc.
  • Nipro Medical Corporation
  • Smiths Group Plc
  • Metier Medical Limited
  • Olympus Corporation
簡介目錄
Product Code: KSI061611907

The global safety needles market was valued at US$381.804 million in 2020 and is forecasted to reach US$910.035 million by 2027, growing at a CAGR of 13.21%.

Safety needles are advanced needs having the feature of an inbuilt safety mechanism that has the capability to avoid needle-linked injuries to the patients. The prime reason which is expected to drive the market growth during the forecasted period is the growing advent of diseases and rising vaccination in an attempt to avoid chronic diseases. With rising complexities in lifestyle and the growing prevalence of chronic diseases, expenditure on diagnosis, treatments, and vaccinations has surged significantly, which has increased the market for safety needles. Furthermore, demand for single-use safety needles for better prevention against potential infection of unwanted pathogens entering the body has provided a new opportunity for growth for the industry. Moreover, an increase in the geriatric population and demand for safe needles for better body suitability also drive the market growth. Robust investment by the government in the healthcare sector is also projected to provide stable growth.

Geographically, the global safety needles are divided into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific regions for the study. The Asia Pacific and North American regions are expected to hold a significant market share. The Asia Pacific region has been emerging as a medical hub. Compared to their countries, Americans and the European population find medical treatment in this region more cost-effective and cheap. An average American can save up to 90% of the expenditure on healthcare if the patient gets treatment from the Asia Pacific region. Furthermore, rising healthcare infrastructure and facilities in the region will further expand the medical tourism market and provide substantial growth for safety needles.

The European region has observed a high rise in the proportion of the geriatric population and a significant increase in chronic, especially cardiovascular disease, which is projected to create the demand for safety syringes for diagnosis, treatment, and medicines intake.

Growth Factor

  • Rising healthcare expenditure and instances of diseases.

One of the prime reasons driving the market growth of safety needles is rising healthcare expenditure and instances of diseases. With growing complexities in lifestyle, a surge in cases of cardiovascular diseases has increased. Diagnosis, treatment, and medicine intake have increased significantly, which has raised safety needle adaption. Data from World Health Organization (WHO) shows that in 2019, 17.9 patients lost their lives owing to cardiovascular illnesses, which accounted for 32% of deaths in the year. 6.460 million deaths among patients under 65 years of age were caused by CVDs. Rising instances of chronic diseases have significantly increased health expenditure for better healthcare. Data from World Bank shows that per capita health expenditure has increased globally from US$999.104 in 2015 to US$1,111.082 in 2018. Increasing health expenditure and treatment are expected to surge the market for safety needles. Furthermore, international organizations have also taken the initiative to reduce the burden of chronic diseases through awareness programs, medication, and treatments. WHO aims to reduce the global prevalence of blood pressure issues by 25% from 2010 to 2025. WHO had declared that 50% of the beneficiaries under this program will receive continuous drug therapy and other treatments to prevent CVDs linked death by 2025. Promising prevention and treatment prospects are expected to increase the market opportunities.

Market Restraint

  • Rising syringe and needle waste create an environmental threat.

A major problem faced by the safety needle industry is the disposal of needles. Safety syringes are dominantly single-use syringes, and their improper disposal creates syringes and needles pollution. With the rising usage of needles and syringes, a surge in syringe pollution has been observed worldwide. In March 2021, San Francisco collected more than 13,000 syringes and needles waste, an increase of 10 times than a decade ago. Furthermore, improper disposal of needles raises the chances of spreading diseases such as HIV and hepatitis. The surging needles market is expected to increase further pollution, which degrades the environment and hence has raised concerns.

COVID-19 Insights

The coronavirus pandemic boosted the demand for safe needles globally. With the outbreak of the virus, the medical industry indulged in the formulation of vaccines and treatments to prevent the spread of the virus. The discovery of covid vaccines in late 2020 and the surging demand for vaccination boosted the market demand for safety needles. Data from Our World in Data shows that globally, till September 2021, 44.1% of the global population has received at least one dose of the covid vaccine. Rising vaccination has increased the demand for syringes and needles, which will boost the market for safe needles in the next couple of years.

Key Market Segments

  • By Type

Active Safety Needles

Passive Safety Needles

  • By Route Of Administration

Subcutaneous

Intravenous

Others

  • By End Users

Hospitals and clinics

Ambulatory care centers

Diagnostic centers

Others

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • United Kingdom
  • Germany
  • Spain
  • France
  • Others

Middle East and Africa

  • UAE
  • Saudi Arabia
  • Others

Asia Pacific

  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Powers of Buyers
    • 4.3.3. Threat of Substitutes
    • 4.3.4. The Threat of New Entrants
    • 4.3.5. Competitive Rivalry in Industry
  • 4.4. Industry Value Chain Analysis

5. GLOBAL SAFETY NEEDLES MARKET, BY TYPE

  • 5.1. Introduction
  • 5.2. Active Safety Needles
  • 5.3. Passive Safety Needles 

6. GLOBAL SAFETY NEEDLES MARKET, BY ROUTE OF ADMINISTRATION

  • 6.1. Introduction
  • 6.2. Subcutaneous  
  • 6.3. Intravenous
  • 6.4. Others 

7. GLOBAL SAFETY NEEDLES MARKET, BY END-USERS

  • 7.1. Introduction
  • 7.2. Hospitals and clinics
  • 7.3. Ambulatory care centers
  • 7.4. Diagnostic centers
  • 7.5. Others 

8. GLOBAL SAFETY NEEDLES MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom 
    • 8.4.4. Spain 
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. South Korea
    • 8.6.4. Taiwan
    • 8.6.5. Thailand
    • 8.6.6. Indonesia 
    • 8.6.7. Japan
    • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisition, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

  • 10.1. BD
  • 10.2. Cardinal Health
  • 10.3. B. Braun Melsungen Ag
  • 10.4. Medline Industries, Inc.
  • 10.5. Johnson & Johnson Services, Inc.
  • 10.6. Nipro Medical Corporation
  • 10.7. Smiths Group Plc
  • 10.8. Metier Medical Limited
  • 10.9. Olympus Corporation